Pepke-Zaba J - Search Results

1

Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension.

Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, Walker C, Budd DC, Pepke-Zaba J, Morrell NW. Soon E, et al. Circulation. 2010 Aug 31;122(9):920-7. doi: 10.1161/CIRCULATIONAHA.109.933762. Epub 2010 Aug 16. Circulation. 2010. PMID: 20713898

2

Pulmonary hypertension in patients with COPD: NO treatment?

Pepke-Zaba J, Morrell NW. Pepke-Zaba J, et al. Thorax. 2003 Apr;58(4):283-4. doi: 10.1136/thorax.58.4.283. Thorax. 2003. PMID: 12668784 Free PMC article. No abstract available.

3

Atrial septostomy in the treatment of severe pulmonary arterial hypertension.

Reichenberger F, Pepke-Zaba J, McNeil K, Parameshwar J, Shapiro LM. Reichenberger F, et al. Thorax. 2003 Sep;58(9):797-800. doi: 10.1136/thorax.58.9.797. Thorax. 2003. PMID: 12947142 Free PMC article.

4

The endothelin system and its role in pulmonary arterial hypertension (PAH).

Pepke-Zaba J, Morrell NW. Pepke-Zaba J, et al. Thorax. 2005 Jun;60(6):443-4. doi: 10.1136/thx.2004.031724. Thorax. 2005. PMID: 15923241 Free PMC article. No abstract available.

5

Large granular lymphocyte leukaemia: a curable form of pulmonary arterial hypertension [corrected].

Howard LS, Chatterji S, Morrell NW, Pepke-Zaba J, Exley AR. Howard LS, et al. Hosp Med. 2005 Jun;66(6):364-5. doi: 10.12968/hmed.2005.66.6.18407. Hosp Med. 2005. PMID: 15974171 No abstract available.

6

Bosentan in inoperable chronic thromboembolic pulmonary hypertension.

Hughes R, George P, Parameshwar J, Cafferty F, Dunning J, Morrell NW, Pepke-Zaba J. Hughes R, et al. Thorax. 2005 Aug;60(8):707. doi: 10.1136/thx.2005.046961. Thorax. 2005. PMID: 16061720 Free PMC article. No abstract available.

7

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.

McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J. McKenna SP, et al. Qual Life Res. 2006 Feb;15(1):103-15. doi: 10.1007/s11136-005-3513-4. Qual Life Res. 2006. PMID: 16411035

8

Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.

Reichenberger F, Mainwood A, Doughty N, Fineberg A, Morrell NW, Pepke-Zaba J. Reichenberger F, et al. Respir Med. 2007 Feb;101(2):217-22. doi: 10.1016/j.rmed.2006.05.019. Epub 2006 Jul 10. Respir Med. 2007. PMID: 16831539 Free article.

9

Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension.

Suntharalingam J, Machado RD, Sharples LD, Toshner MR, Sheares KK, Hughes RJ, Jenkins DP, Trembath RC, Morrell NW, Pepke-Zaba J. Suntharalingam J, et al. Thorax. 2007 Jul;62(7):617-22. doi: 10.1136/thx.2006.070680. Epub 2007 Feb 7. Thorax. 2007. PMID: 17287300 Free PMC article.

10

Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).

Suntharalingam J, Hughes RJ, Goldsmith K, Doughty N, George P, Toshner M, Sheares KK, Pepke-Zaba J. Suntharalingam J, et al. Vascul Pharmacol. 2007 Jun;46(6):449-55. doi: 10.1016/j.vph.2007.01.008. Epub 2007 Feb 12. Vascul Pharmacol. 2007. PMID: 17368113 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters